| Anemia in chronic kidney disease: from pathophysiology and current treatments, to future agents J Portolés, L Martín, JJ Broseta, A Cases Frontiers in Medicine 8, 642296, 2021 | 187 | 2021 |
| Humoral and cellular responses to mRNA-1273 and BNT162b2 SARS-CoV-2 vaccines administered to hemodialysis patients JJ Broseta, D Rodríguez-Espinosa, N Rodríguez, M del Mar Mosquera, ... American Journal of Kidney Diseases 78 (4), 571-581, 2021 | 129 | 2021 |
| Medium cut-off dialyzer versus eight hemodiafiltration dialyzers: comparison using a global removal score F Maduell, L Rodas, JJ Broseta, M Gomez, M Xipell, E Guillen, ... Blood Purification 48 (2), 167-174, 2019 | 87 | 2019 |
| High‐permeability alternatives to current dialyzers performing both high‐flux hemodialysis and postdilution online hemodiafiltration F Maduell, L Rodas, JJ Broseta, M Gómez, M Xipell Font, A Molina, ... Artificial Organs 43 (10), 1014-1021, 2019 | 46 | 2019 |
| Humoral response of the mRNA-1273 SARS-CoV-2 vaccine in peritoneal dialysis patients D Rodríguez-Espinosa, JJ Broseta, F Maduell, JL Bedini, M Vera Kidney International 100 (2), 476-477, 2021 | 33 | 2021 |
| SARS-CoV-2 infection in a Spanish cohort of CKD-5D patients: prevalence, clinical presentation, outcomes, and de-isolation results JJ Broseta, D Rodríguez-Espinosa, E Cuadrado, E Guillen-Olmos, ... Blood Purification 50 (4-5), 531-538, 2021 | 20 | 2021 |
| Comparison of solute removal properties between high‐efficient dialysis modalities in low blood flow rate F Maduell, JJ Broseta, L Rodas, E Montagud‐Marrahi, ... Therapeutic Apheresis and Dialysis 24 (4), 387-392, 2020 | 19 | 2020 |
| Comparison of four medium cut-off dialyzers F Maduell, JJ Broseta, D Rodríguez-Espinosa, J Del Risco, LM Rodas, ... Clinical Kidney Journal 15 (12), 2292-2299, 2022 | 18 | 2022 |
| Incidence of severe breakthrough SARS-CoV-2 infections in vaccinated kidney transplant and haemodialysis patients D Rodríguez-Espinosa, E Montagud-Marrahi, J Cacho, C Arana, ... Journal of Nephrology 35 (3), 769-778, 2022 | 17 | 2022 |
| Improved control of secondary hyperparathyroidism in hemodialysis patients switching from oral cinacalcet to intravenous etelcalcetide, especially in nonadherent patients M Xipell, E Montagud-Marrahi, MV Rubio, R Ojeda, M Arias-Guillén, ... Blood Purification 48 (2), 106-114, 2019 | 16 | 2019 |
| Optimization of dialysate bicarbonate in patients treated with online haemodiafiltration E Montagud-Marrahi, J Broseta, D Rodriguez-Espinosa, R Lidia, ... Clinical Kidney Journal 14 (3), 1004-1013, 2021 | 15 | 2021 |
| Humoral response after three doses of mRNA-1273 or BNT162b2 SARS-CoV-2 vaccines in hemodialysis patients JJ Broseta, D Rodríguez-Espinosa, E Cuadrado, N Rodríguez, JL Bedini, ... Vaccines 10 (4), 522, 2022 | 14 | 2022 |
| Evaluation of the influence of the surface membrane and blood flow in medium «cut-off»(MCO) dialyzers F Maduell, L Rodas, JJ Broseta, M Gómez, E Montagud-Marrahi, ... Nefrología (English Edition) 39 (6), 623-628, 2019 | 14 | 2019 |
| Health-related quality of life of X-linked hypophosphatemia in Spain MIL Yanes, M Diaz-Curiel, P Peris, C Vicente, S Marin, M Ramon-Krauel, ... Orphanet Journal of Rare Diseases 17 (1), 298, 2022 | 13 | 2022 |
| Evaluation and comparison of polysulfone TS‐UL and PMMA NF‐U dialyzers versus expanded hemodialysis and postdilution hemodiafiltration F Maduell, JJ Broseta, D Rodríguez‐Espinosa, E Hermida‐Lama, ... Artificial Organs 45 (9), E317-E323, 2021 | 13 | 2021 |
| Hemodiafiltration (HDF) versus expanded hemodialysis (HDx) F Maduell, JJ Broseta Seminars in Dialysis 35 (5), 436-439, 2022 | 12 | 2022 |
| Mortality in hemodialysis patients with Covid-19, the effect of paricalcitol or calcimimetics MD Arenas Jimenez, E González-Parra, M Riera, A Rincon Bello, ... Nutrients 13 (8), 2559, 2021 | 11 | 2021 |
| Determining factors for hemodiafiltration to equal or exceed the performance of expanded hemodialysis F Maduell, JJ Broseta, M Gómez, P Racionero, E Montagud‐Marrahi, ... Artificial Organs 44 (10), E448-E458, 2020 | 11 | 2020 |
| Multimodal strategies for the diagnosis and management of refractory congestion. an integrated cardiorenal approach D Rodríguez-Espinosa, J Guzman-Bofarull, JC De La Fuente-Mancera, ... Frontiers in Physiology 13, 913580, 2022 | 10 | 2022 |
| Lipidic profiles of patients starting peritoneal dialysis suggest an increased cardiovascular risk beyond classical dyslipidemia biomarkers JH Lluesa, LC López-Romero, JJB Monzó, MR Marugán, IV Boyano, ... Scientific Reports 12 (1), 16394, 2022 | 9 | 2022 |
Aleix CasesConsultor Senior. Servicio de Nefrologia. Hospital Clinic. BarcelonaDirección de correo verificada de clinic.cat
